For sterile pharmaceutical and fill-finish teams
Container, closure, and fill inspection with validation-ready evidence for every unit.
Turn fill-finish inspection signals into evidence-backed deviation and review packets.
particulatefillauditDeviation · review required
From factory signal to audit-ready record
Human-controlled
System preparedHuman approval requiredNo automatic release
Where teams usually start
- Fill / closure verification
- Particulate & cosmetic inspection
- Final container / labeling check
Example part & rule
Example part Machined titanium implant body
Reject a surface pit above 0.2 mm in a critical region.
measured 0.35 mmlimit 0.2 mm
REJECTsurface pitscratchcontaminationmolding flaw
Discovery questions for the conversation
- Which container or closure defect is hardest to catch consistently today?
- What evidence do auditors ask for on a released batch?
- Where does manual visual inspection vary most between operators?
Which inspection station should we map first?
The goal is to identify one station where this could matter — then validate with your approved parts and criteria.
Build the pilot planThis is an example workflow for sterile pharma & fill-finishteams — a hypothesis, not a claim about any specific company's process.
Demo scenes are illustrative and use deterministic product scenarios. Regulated decisions remain human-controlled.